Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harari

Showing results (221-230 of 305) with videos related to

Pageof 31
Sort By:
Head & Neck|February 15, 2020
Clinical outcomes for larynx patients with cancer treated with refinement of high-dose radiation treatment volumesAdam R Burr, Paul M Harari, Alyx M Haasl, et al.
Head and Neck Pathology|May 14, 2025
Clinicopathologic and Molecular Characterization of SMARCB1-Deificient Sinonasal Carcinomas -A Systematic Study from a Single Institution CohortQinyuan Li, Tarek Abi-Saab, Andrey Prilutskiy, et al.
OTO Open|March 31, 2023
Functional Outcomes After Transoral Plus Lateral Pharyngotomy Approach for Advanced Oral and Oropharyngeal TumorsSophia M Colevas, Emily C Merfeld, Zachary E Pflum, et al.
Ebiomedicine|October 21, 2021
Primary head and neck tumour-derived fibroblasts promote lymphangiogenesis in a lymphatic organotypic co-culture modelKarina M Lugo-Cintrón, José M Ayuso, Mouhita Humayun, et al.
Head & Neck|March 4, 1998
Planned postradiotherapy neck dissection in patients with advanced head and neck cancerT S Boyd, P M Harari, S P Tannehill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2010
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptorsTim J Kruser, Deric L Wheeler, Eric A Armstrong, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2017
Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomasHuaising C Ko, Paul M Harari, Ryan M Sacotte, et al.
Head & Neck|November 11, 2021
Defining high-risk elective contralateral neck radiation volumes for oropharynx cancerMatthew E Witek, Neil M Woody, Hima B Musunuru, et al.
Technology in Cancer Research & Treatment|September 20, 2006
Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapyJames S Welsh, Michael Lock, Paul M Harari, et al.
Cancer Medicine|January 27, 2015
Xenograft assessment of predictive biomarkers for standard head and neck cancer therapiesAndrew P Stein, Adam D Swick, Molly A Smith, et al.
Pageof 31

Showing results (221-230 of 305) with videos related to

Sort By:
Pageof 31
Head & Neck|February 15, 2020
Clinical outcomes for larynx patients with cancer treated with refinement of high-dose radiation treatment volumesAdam R Burr, Paul M Harari, Alyx M Haasl, et al.
Head and Neck Pathology|May 14, 2025
Clinicopathologic and Molecular Characterization of SMARCB1-Deificient Sinonasal Carcinomas -A Systematic Study from a Single Institution CohortQinyuan Li, Tarek Abi-Saab, Andrey Prilutskiy, et al.
OTO Open|March 31, 2023
Functional Outcomes After Transoral Plus Lateral Pharyngotomy Approach for Advanced Oral and Oropharyngeal TumorsSophia M Colevas, Emily C Merfeld, Zachary E Pflum, et al.
Ebiomedicine|October 21, 2021
Primary head and neck tumour-derived fibroblasts promote lymphangiogenesis in a lymphatic organotypic co-culture modelKarina M Lugo-Cintrón, José M Ayuso, Mouhita Humayun, et al.
Head & Neck|March 4, 1998
Planned postradiotherapy neck dissection in patients with advanced head and neck cancerT S Boyd, P M Harari, S P Tannehill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2010
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptorsTim J Kruser, Deric L Wheeler, Eric A Armstrong, et al.
Journal of Cancer Research and Clinical Oncology|July 29, 2017
Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomasHuaising C Ko, Paul M Harari, Ryan M Sacotte, et al.
Head & Neck|November 11, 2021
Defining high-risk elective contralateral neck radiation volumes for oropharynx cancerMatthew E Witek, Neil M Woody, Hima B Musunuru, et al.
Technology in Cancer Research & Treatment|September 20, 2006
Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapyJames S Welsh, Michael Lock, Paul M Harari, et al.
Cancer Medicine|January 27, 2015
Xenograft assessment of predictive biomarkers for standard head and neck cancer therapiesAndrew P Stein, Adam D Swick, Molly A Smith, et al.
Pageof 31